Tempus AI and Recursion Pharmaceuticals extended their data license agreement through November 2029 and revised the contract's fee structure. Up to $84 million in discretionary payments over ...
"Just memorize it, that's how it is" is a big 'no-no'When you are studying a language,you encounter this phrase many times.Why does German have,der, die, das, den, dem, des...so many articles?Why does ...
On September 18, Recursion Pharmaceuticals (RXRX) rose 8.19% from the previous day, closing at $3.83. And what is worth noting is the trading volume of 44.3 million shares that day. The stock price ...
AI healthcare stocks rallied broadly on September 17. AI drug design company $Absci Corp (ABSI.US)$ jumped more than 15%, while $Tempus AI (TEM.US)$ , which has attracted investments from Cathie ...
Anthropic published a research post on September 17, 2026, reporting that Claude optimized more than 30 open-source ...
Software engineering interviews, especially at top tech companies, heavily emphasize algorithms, data structures, and problem ...
About 252 million years ago, at the end of the Permian Period, a large proportion of species on Earth rapidly became extinct.
Today we're releasing data on models accelerating research at OpenAI. Recursive self-improvement could be the most important contributor to AI capabilities over the next few years, but by default it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results